Drug Store News6d
Biocon Pharma gets FDA nod for norepinephrine bitartrate injection
Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with acute hypotension.
Biocon gains 2% on US FDA nod for ANDA Norepinephrine Bitartrate Injection
US Food and Drug Administration (US FDA) for its ANDA Norepinephrine Bitartrate Injection USP, 4 mg/4 mL (1 mg/mL) ...
IndiaInfoline6d
Biocon Pharma Gains USFDA Approval for Norepinephrine and Key Therapies
This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.
Biocon rises after subsidiary gets US FDA approval for Norepinephrine Bitartrate Injection
Biocon added 1.34% to Rs 348.55 after the company's wholly owned subsidiary Biocon Pharma announced the receipt of U.S Food and Drug Administration (US FDA) approval for its ANDA Norepinephrine ...
CNBCTV186d
Biocon unit gets USFDA nod for blood pressure treatment drug
Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...
Biocon subsidiary secures FDA approval for critical blood pressure medication
Biocon Pharma Limited receives FDA approval for Norepinephrine Bitartrate Injection USP, expanding its complex drug portfolio ...
Medical Dialogues6d
Biocon Pharma gets USFDA approval for BP-raising injection in adults with acute hypotension
Bengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...
Investing.com India6d
Biocon Gains USFDA Nod for Blood Pressure Drug—What It Means for Investors
The approval covers the norepinephrine bitartrate injection 4 mg/4 mL (1 mg/mL) single-dose vial, which can now be ...